Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 19 - Preventing Cognitive Decline and Dementia

  • Edited by Kenneth M. Heilman, University of Florida, Stephen E. Nadeau, University of Florida
  • Book:
    Cognitive Changes and the Aging Brain
    Published online:
    30 November 2019
    Print publication:
    05 December 2019, pp 291-306

  • Summary

    Early diagnosis and treatment, delay of progression, and prevention of Alzheimer’s disease (AD) are all interrelated and are targets for pharmaceutical and behavioral interventions. Depending on their mechanisms, medications directed at treatment or aimed at slowing the progression of disease may be candidates for disease prevention as well. As we have learned more about AD over the past two decades, experienced clinicians have become increasingly skilled at diagnosing AD earlier in the course of this disease and on the basis of milder symptoms. An isolated symptom of memory loss, termed mild cognitive impairment (MCI), appears to be one of the most common initial presentations of AD. Cerebrospinal fluid (CSF) analysis, neuroimaging, and blood biomarkers hold promise for improving diagnostic certainty even in cases with mild cognitive symptoms. Researchers worldwide are seeking to identify treatments or changes in lifestyle (e.g., diet, exercise, and mental activity) that would decrease the risk of developing AD.